Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Electrical Current01:10

Electrical Current

6.9K
Electrical current is defined as the rate at which charge flows. When there is a large current present, such as that used to run a refrigerator, a large amount of charge moves through the wire in a small amount of time. If the current is small, such as that used to operate a handheld calculator, a small amount of charge moves through the circuit over a long period of time. The SI unit for current is the ampere (A), named for the French physicist André-Marie Ampère (1775–1836).
6.9K
Significance of Displacement Current01:27

Significance of Displacement Current

5.8K
A displacement current is analogous to a real current in Ampère's law, participating in Ampère's law the same way as the usual conduction current. However, it is produced by a changing electric field. Displacement current is defined in terms of a time-varying electric field, and also has an associated displacement current density. By adding a term accounting for displacement current, Maxwell modified the existing Ampère's law, which is now called generalized Ampère's law.
5.8K
Current Trends in Nursing I01:28

Current Trends in Nursing I

5.3K
Current trends in nursing include:
5.3K
Current Trends in Nursing II01:30

Current Trends in Nursing II

3.4K
Trends in nursing are multifactorial and associated with changes in society, within the nursing profession, and in other professions. Notably, telehealth and remote nursing contribute to successful healthcare delivery for numerous patients and help reduce stress for nurses due to nursing shortages. Nurses can reach patients, monitor their conditions, and interact with them using computers, audio, visual accessories, and telephones—for example, remote patient monitoring systems. Likewise,...
3.4K
Charge and Current01:14

Charge and Current

5.2K
Electric charge is the most fundamental quantity in an electric circuit. The effects of electric charge are encountered daily, such as when a wool sweater sticks to the human body or when a person receives a shock while walking on a carpet.
Charge is an inherent property of the atomic particles that make up matter and is measured in units called coulombs (C). Matter is composed of atoms, each consisting of electrons, protons, and neutrons. Electrons have a negative charge (-e), while protons...
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protein language models accurately predict polymorphic peptide-modulated NK cell receptor-HLA class I interaction strengths.

Science advances·2026
Same author

CD40L and IL-4 lymph node-associated signals protect B cells from rituximab-induced ADCC via KIR and NKG2A.

Clinical and experimental immunology·2026
Same author

Using In silico models to predict lymphocyte activation and development in a data rich era.

Immunoinformatics (Amsterdam, Netherlands)·2026
Same author

Characterisation of People Living With Chronic Hepatitis B Virus Infection in England and Stratification by HBsAg Levels: A Cross-Sectional Study.

Journal of viral hepatitis·2025
Same author

Hepatitis B Virus (HBV) Treatment Eligibility in the UK: Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines.

Journal of viral hepatitis·2025
Same author

CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axis.

Immunotherapy advances·2025

Related Experiment Video

Updated: Jan 22, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
05:06

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis

Published on: October 24, 2015

12.8K

Immunotherapy for hepatocellular carcinoma: Current and future.

Michael P Johnston1, Salim I Khakoo2

  • 1Department of Hepatology, Southampton General Hospital, University Hospital Southampton, Southampton SO16 6YD, United Kingdom.

World Journal of Gastroenterology
|July 12, 2019
PubMed
Summary

Hepatocellular carcinoma (HCC) treatments are advancing with novel immunotherapies. This review explores emerging agents like checkpoint inhibitors and vaccines, offering new hope for patients with advanced liver cancer.

Keywords:
Adoptive cell therapyCancer vaccineCheckpoint inhibitorHepatocellular carcinomaImmunotherapyLiver cancerOncolytic virus

More Related Videos

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

6.1K
Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
10:35

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Published on: September 25, 2013

37.1K

Related Experiment Videos

Last Updated: Jan 22, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
05:06

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis

Published on: October 24, 2015

12.8K
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

6.1K
Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
10:35

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Published on: September 25, 2013

37.1K

Area of Science:

  • Hepatology and Oncology
  • Immunotherapy Research
  • Cancer Therapeutics

Background:

  • Hepatocellular carcinoma (HCC) incidence is rising, often linked to chronic liver disease and non-alcoholic fatty liver disease.
  • Many patients present with advanced HCC, ineligible for standard treatments like surgery or locoregional therapy.
  • Current HCC therapies benefit only a small patient subset, highlighting the need for innovative approaches.

Purpose of the Study:

  • To review the emerging landscape of immunotherapies for hepatocellular carcinoma.
  • To discuss novel agents including checkpoint inhibitors, cytokine blockade, oncolytic viruses, cellular therapies, and vaccines.
  • To explore the potential of these immunotherapies, both as monotherapy and in combination treatments.

Main Methods:

  • Review of current scientific literature on HCC immunotherapies.
  • Categorization of emerging immunotherapeutic strategies.
  • Analysis of early-phase trial data and potential combination therapies.

Main Results:

  • Immunotherapies, including checkpoint inhibitors, show significant promise for HCC treatment.
  • Emerging agents aim to either boost existing immune responses or stimulate new ones.
  • Combination therapies, integrating immunotherapy with other modalities, are anticipated to improve outcomes.

Conclusions:

  • Immunotherapy represents a rapidly evolving and promising frontier in HCC treatment.
  • Novel agents and combination strategies offer new therapeutic opportunities for advanced liver cancer.
  • Further research and clinical trials are essential to fully realize the potential of these treatments.